New updates in this third version of the American College of Rheumatology’s guidance include a recommendation for dual therapy with IVIg and...
Fast-track clinics are using vascular ultrasound to streamline diagnosis of giant cell arteritis, but the United States has a way to go to catch...
COVID-19 interventions may have reduced transmission of the associated enteroviruses.
Overall, the data suggest that the risk-benefit balance for RZV "remains favorable."
Researchers conducted an indirect treatment comparison on the efficacy of the three FDA-approved treatment options for adults with AQP4+ NMOSD.
An extension study found that the synthetic medium-chain triglyceride triheptanoin improved brain energy and caudate atrophy in Huntington’s...
An extension study of the Nrf2 activator omaveloxolone in people with Friedreich’s ataxia showed benefit out to more than 2 years.
The vast majority of the children had severe language, cognitive, and motor delays, yet there were also "important differences in neurological and...
The findings point to potential future biomarkers in screening for ALS.
The intravenous infusion supplements GAA and helps reduce glycogen accumulation.